Abstract
Background Vaccination was the single most effective measure in mitigating the impact of the COVID-19 pandemic. Our study aims to quantify the impact of vaccination programmes during this initial year of vaccination by estimating the number of case fatalities avoided, having Sweden as a case study.
Methods Using Swedish data on age-specific reported incidence, vaccination uptake, and contact structures, along with age-specific estimates on the vaccine efficacies and under-reporting from the literature, we fit a Bayesian SEIR epidemic model with time-varying community contact rate β(t) for COVID-19 incidence. By adding age-specific infection fatality rates, we obtain an estimate of about 5,540 (95% PI: 5,390-5,690) for the number of case fatalities from the fitted model. This estimate aligns closely with the reported 5,430 case fatalities during the same period. We then use the estimated contact rate β(t) in a counterfactual analysis where the population is unvaccinated, leading to more infections and fatalities.
Findings The counterfactual analysis result in a severe epidemic outbreak during the early autumn of 2021, resulting in about 52,600 (49,900-55,500) number of case fatalities. Consequently, the number of lives saved by the vaccination program is estimated to be about 47,100 (44,500-49,800), out of which 6,460 are directly saved and 40,600 are indirectly saved, mainly by drastically reducing the severe outbreak in the early autumn of 2021, which would have occurred without vaccination and unchanged community contact rate.
Interpretation Our mathematical model is used to analyze the impact of COVID-19 vaccination on lives saved in Sweden during 2021, but the same methodology can be applied to other countries. The counterfactual analysis offers insights into an alternative trajectory of the pandemic without vaccination. By incorporating estimated vaccination-related parameters, age-specific infection fatality ratio and under-reporting, our model estimates the number of case fatalities avoided. The results not only show the direct impact of vaccination on reducing deaths for infected individuals but also shed light on the indirect effects of reduced transmission dynamics.
Funding NordForsk (project number 105572).
Evidence before this study Vaccination against COVID-19 has been proven to reduce infection rates, hospitalizations, and mortality. Observational studies and clinical trials have demonstrated the efficacy COVID-19 vaccines, and mathematical modeling studies have been conducted to predict the potential outcomes of vaccination programmes under different scenarios. These models have provided insights into the benefits of achieving high vaccination coverage and the consequences of delays or interruptions in vaccine distribution. There remains a gap in analyses that quantify the impact of the vaccination programme in Sweden by comparing actual outcomes with a scenario without vaccination. This study aims to fill this gap by employing a robust counterfactual analysis method to provide a clearer picture of the COVID-19 vaccination impact in Sweden. This approach offers a understanding of the impact of vaccination by isolating the effects of the vaccination from other interventions. For our literature review, we have searched PubMed for “vaccination counterfactual analysis”, “SEIR model vaccination impact”, “quantifying effect of COVID-19 vaccination” and “COVID-19 IFR”. The Swedish Public Health Agency has provided country-specific data for Sweden.
Added value of this study The Bayesian SEIR model presented in this paper provides a flexible and data-driven framework to assess the effectiveness of vaccination strategies. Using age- and country-specific data and parameters on reported cases, under-reporting and infection fatality rate (IFR), we can quantify the effect of vaccination in Sweden 2021. This study compares the case fatalities in a factual analysis with a counterfactual analysis, which has the same contact rates but with a unvaccinated population. The comparison allows an estimate of the number of lives saved from the vaccination. The methodology can be used to evaluate the effect of vaccination in other countries, but also for other counterfactual scenarios such as different vaccination schemes.
Implications of all the available evidence Our findings highlight the critical role of vaccination in mitigating COVID-19-related mortality. Through the counterfactual analysis provided by the SEIR epidemic model, we gain insights into the effects of vaccination programmes. Beyond reducing deaths directly attributable to COVID-19 infection vaccination also exerts a broader societal impact by curbing transmission rates and easing strain on healthcare systems. Moreover, by quantifying the number of lives saved through vaccination efforts, we offer policymakers and public health officials invaluable data for optimizing future vaccination strategies and reinforcing the importance of widespread vaccine uptake. The insights gained from this study not only show the effectiveness of vaccination in saving lives but also provide a robust framework of a data-driven approach to guide evidence-based decision-making and shaping vaccination policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NordForsk (project number 105572).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used for our analysis were publicly avaliable prior to the initialisation of this study. COVID-19 case data and vaccination is avaliable from the Swedish public health agency (PHA): https://www.folkhalsomyndigheten.se/sm ittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/statistik-och-analyser/ Report on Infection fatality rate from the PHA: https://www.folkhalsomyndigheten.se/contentassets/da0321b738ee4f0686d758e069e18caa/skattning-letalitet-covid-19-stockholms-lan.pdf/. Demographics for Sweden is avalable from Statistics Sweden: https://www.scb.se/hitta-statistik/sverige-i-siffror/manniskorna-i-sverige/befolkningspyramid-for-sverige/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Felix Günther changed affiliation after his work on this project and now works at the Department of Infectious Disease Epidemiology, Robert Koch Institute, Germany.
Data Availability
All data used for our analysis are available online at https://github.com/fannybergstrom/vaccination_sweden/
